GlassScriptPhysician profile
Joshua I Mozes
NPI 1679733414
$26,010.14
in general payments reported to CMS, 2019-2025
24 companies · $670 in 2025
The $670 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,506 · 2020: $9,622 · 2021: $665 · 2022: $2,734 · 2023: $2,221 · 2024: $2,592 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,445 · Travel and Lodging: $1,023 · Education: $14.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,445.41 |
| Travel and Lodging | $1,022.81 |
| Education | $14.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,547.40 | 2019-2025 | Amplatzer Amulet, Jot Dx, Ensite Precision |
| Boston Scientific Corporation | $3,473.47 | 2019-2025 | Watchman Access System, Ingevity Mri, General - Therapies |
| Impulse Dynamics (USA) INC. | $513.78 | 2023-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $259.68 | 2021-2025 | Pulseselect, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Pfizer INC. | $203.73 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $165.87 | 2023-2025 | |
| Siemens Medical Solutions USA, INC. | $146.69 | 2023 | Biograph Horizon-3r |
| E.R. Squibb & Sons, L.L.C. | $138.64 | 2021-2025 | Camzyos, Eliquis |
| Philips North America LLC | $87.53 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $63.21 | 2024 | Arcalyst |
| Biotronik INC. | $58.64 | 2023 | Biomonitor, Rivacor 7 Dr-T, Acticor 7 Vr-T Dx |
| Amgen INC. | $45.91 | 2023 | Repatha |
| Alnylam Pharmaceuticals INC. | $43.57 | 2023-2025 | Amvuttra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.85 | 2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.38 | 2023 | Jardiance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $29.44 | 2025 | |
| Heartflow, INC. | $26.22 | 2023 | Ffrct |
| Baxter Healthcare | $24.67 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lilly USA, LLC | $23.82 | 2025 | Zepbound |
| Irhythm Technologies, INC. | $23.69 | 2021 | |
| Medtronic Vascular, INC. | $18.63 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $16.81 | 2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $16.26 | 2025 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $15.25 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Mozes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.